Objectives. We assessed the willingness of gay and bisexual men, who have high rates of anal cancer that might be prevented through regular screening, to receive anal Papanicolaou tests. Methods. We surveyed a national sample of men aged 18 to 59 years who self- identified as gay (n=) or bisexual (n=70). Results. If approved for use in males, HPV vaccine may offer great benefits to gay and bisexual men due to their high rates of HPV infection and HPV-associated anal cancer. We currently know little about the acceptability of the vaccine among gay and bisexual men. In this national sample of gay and bisexual men, most were willing. () reported a positive association between self-controlling coping (i.e. keeping one's feelings to oneself) and unprotected anal intercourse in a sample of non- monogamous gay and bisexual men. In another study, Martin () examined coping as a predictor of sexual behavior intent in a sample of gay men.